Cover Image
市場調查報告書

胃輕癱:全球臨床實驗檢討 (2015年前半期)

Gastroparesis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 324949
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
胃輕癱:全球臨床實驗檢討 (2015年前半期) Gastroparesis Global Clinical Trials Review, H2, 2016
出版日期: 2016年11月30日 內容資訊: 英文 93 Pages
簡介

本報告提供胃不全麻痺相關之臨床研究最新趨勢調查,提供您地區·進展·PHASE·募集情況別之實驗量,代表性贊助商,開發中的治療藥資訊,並彙整全球各國的主要企業·機關的進展狀況,及有潛力的藥劑比較等資訊。

目錄

  • 簡介
    • 胃輕癱
    • 報告指南
  • 各地區的臨床實驗數量
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要國家的臨床實驗數量
      • 歐洲主要5個國家的臨床實驗數量
      • 北美主要國家的臨床實驗數量
      • 中東·非洲主要國家的臨床實驗數量
  • G7各國臨床實驗數量:消化器官系統臨床實驗中胃輕癱的比例
  • G7各國臨床實驗數量:Phase別
  • G7各國臨床實驗數量:各進展狀況
  • E7各國臨床實驗數量:消化器官系統臨床實驗中胃輕癱的比例
  • Phase別臨床實驗數量
    • 進行中的臨床實驗:Phase別
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標達成情形
  • 未完成的臨床實驗數量:胃輕癱的情況
  • 一定期間所採用的實驗對像
  • 贊助商類別的臨床實驗數量
  • 有潛力的贊助商
    • 胃輕癱治療藥臨床實驗的主要參與企業
  • 有潛力的藥劑
  • 最新臨床實驗新聞:胃輕癱相關
  • 臨床實驗簡介
    • 主要企業臨床實驗概要
      • GlaxoSmithKline plc
      • Eli Lilly and Company
      • Theravance Biopharma U.S., Inc.
      • Ocera Therapeutics, Inc.
      • Johnson & Johnson
      • Forest Laboratories, Inc.
      • F. Hoffmann-La Roche Ltd.
      • Evoke Pharma, Inc.
      • Dong-A Socio Group
      • Allegiance Healthcare Corporation
    • 有代表性的研究機關·醫院臨床實驗概要
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Mayo Clinic
      • Johns Hopkins University
      • University of Florida
      • Temple University
      • Royal Adelaide Hospital
      • Skane University Hospital
      • Columbia University
      • Rouen University Hospital
      • University of Iowa
  • 5個有代表性的臨床實驗簡介
  • 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3949CTIDB

GlobalData's clinical trial report, "Gastroparesis Global Clinical Trials Review, H2, 2016" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Gastroparesis Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 90

  • Abbreviations 90
  • Definitions 90
  • Research Methodology 91
  • Secondary Research 91
  • About GlobalData 92
  • Contact Us 92
  • Disclaimer 92
  • Source 93

List of Tables

List of Tables

  • Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
  • Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
  • Gastroparesis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Gastroparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures

List of Figures

  • Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
  • Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
  • Gastroparesis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Gastroparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
  • GlobalData Methodology 91
Back to Top